Public, NASDAQ:XTLB
NASDAQ Capital Market
XTL Biopharmaceuticals Ltd. Appoints A New CFO
Date: Wed, 05 Aug 2009 00:00:00 GMT
Tags:
XTL Biopharmaceuticals Ltd. Receives Notification Of Delisting Determination By NASDAQ Listing Qualifications Panel
Date: Thu, 16 Apr 2009 11:45:00 GMT
Tags:
XTL Biopharmaceuticals Ltd. Receives Notification Of Delisting Determination By NASDAQ Listing Qualifications Panel
Reuters Key Development - Apr 16, 2009
Reuters Key Development - Apr 16, 2009
XTL Biopharmaceuticals Ltd. Announces Acquisition of Use Patent on Recombinant Erythropoietin; To Issue Just Under 50% of Share Capital
Date: Thu, 19 Mar 2009 02:24:00 GMT
Tags:
XTL Biopharmaceuticals Ltd. Announces Acquisition of Use Patent on Recombinant Erythropoietin; To Issue Just Under 50% of Share Capital
Reuters Key Development - Mar 19, 2009
Reuters Key Development - Mar 19, 2009
XTL Biopharmaceuticals Ltd. Announces Receipt Of Nasdaq Notice Of Delisting
Date: Wed, 28 Jan 2009 00:00:00 GMT
Tags:
XTL Biopharmaceuticals Ltd. Announces Receipt Of Nasdaq Notice Of Delisting
Reuters Key Development - Jan 28, 2009
Reuters Key Development - Jan 28, 2009
XTL Biopharmaceuticals Ltd. Implements Restructuring Plan
Date: Mon, 08 Dec 2008 21:35:00 GMT
Tags:
Yahoo! Finance: RSS feed not found
Date: Mon, 20 Mar 2006 08:19:00 GMT
Tags:
RSS feed not found. Please remove this RSS feed or check Yahoo! Finance for more symbols.